Despite significant insider shares, Milestone Pharmaceuticals noted fairly low insider ownership. The absence of recent insider transactions is raising concerns. It's more encouraging if insiders bought more shares in the company.
RECAP S&P 500 Approaches All-Time High US stocks rose, with the$S&P 500 Index(.SPX.US)$approaching its all-time, high as optimism over potential interest rate cuts next year continued to fuel positive sentiment on the last trading week of the year. The S&P 500 closed 0.42% higher at 4,774.75 on the first day of the holiday-shortened trading week. The$Nasdaq Composite Index(.IXIC.US)$gained 0.5% to 15,074.57, while the$NYダウ(.DJI.US)$added 0.4...
FirstStrike Veteran :
awesome article. I would suggest adding the IWM into the mix as it's going to out pace the S and P 500 next year. Just my opinion obviously.
$マイルストーン ファーマシューティカルズ(MIST.US)$Milestone Pharmaceuticals Received An FDA Refusal To File Letter For The New Drug Application For Self-administered Etripamil Nasal Spray For Paroxysmal Supraventricular Tachycardia
$プログレッシブ コーポレーション(PGR.US)$initiated at equal-weight by Morgan Stanley, announced target price at $135.00. $レモネード(LMND.US)$initiated at underweight by Morgan Stanley, announced targe price at $14.00. $バイドゥ(BIDU.US)$was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $160.00 to $190.00. $フィリップ モリス インターナショナル(PM.US)$was upgraded by Citigroup from neutral to buy, increased target price from $10...
Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week. Top Medical News of the Week Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and r...
Gainers： •$イノビズ テクノロジズ(INVZ.US)$+18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands) •$ヒルトップ ホールディングス(HTH.US)$+15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
18
3
2
報告
Dino 64 :
Nio is a pre market mover alright.....DOWN.
マイルストーン ファーマシューティカルズに関するコメント
NEWS
Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
S&P 500 Approaches All-Time High
US stocks rose, with the $S&P 500 Index(.SPX.US)$ approaching its all-time, high as optimism over potential interest rate cuts next year continued to fuel positive sentiment on the last trading week of the year.
The S&P 500 closed 0.42% higher at 4,774.75 on the first day of the holiday-shortened trading week. The $Nasdaq Composite Index(.IXIC.US)$ gained 0.5% to 15,074.57, while the $NYダウ(.DJI.US)$ added 0.4...
$レモネード(LMND.US)$ initiated at underweight by Morgan Stanley, announced targe price at $14.00.
$バイドゥ(BIDU.US)$ was upgraded by Morgan Stanley from equal-weight to overweight, increased target price from $160.00 to $190.00.
$フィリップ モリス インターナショナル(PM.US)$ was upgraded by Citigroup from neutral to buy, increased target price from $10...
Top Medical News of the Week
Lab-grown blood given to humans in world-first trial aimed at combatting rare disorders
Blood grown in a laboratory has been transfused into humans for the first time in a landmark clinical trial that U.K. researchers say could significantly improve treatment for people with blood disorders and r...
• $イノビズ テクノロジズ(INVZ.US)$ +18.7% (selected by "large automotive group manufacturer" to become its direct LiDAR supplier across multiple brands)
• $ヒルトップ ホールディングス(HTH.US)$ +15.7% (commenced a modified "Dutch auction" tender offer to purchase for cash up to $400 mln of its common stock at a price per share not less than $28,00 and not greater than $32.00 less any applicable withholding taxes and without interest usin...
• $アメリカン航空(AAL.US)$ : JP Morgan Upgrades to Neutral From Underweight - PT $26 (from $18)
• $AZEK Co Inc/The(AZEK.US)$ : Citigroup Upgrades to Buy from Neutral - PT $30 (from $36)
• $ボストン・プロパティーズ(BXP.US)$ : Mizuho Upgrades to Buy from Neutral - PT $135 (from $120)
• $ダウ(DOW.US)$ : Citigroup Upgrades To Buy From Neutral - PT $82 (from $70)
• $クローガー(KR.US)$ : Exane Upgrades to Neutral from Underperform - PT $60
• $マイルストーン ファーマシューティカルズ(MIST.US)$ : Piper S...
まだコメントはありません